Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer.

Breast Cancer Research and Treatment
Svetlana BortnikSharon M Gorski

Abstract

Previous studies indicate that breast cancer molecular subtypes differ with respect to their dependency on autophagy, but our knowledge of the differential expression and prognostic significance of autophagy-related biomarkers in breast cancer is limited. Immunohistochemistry (IHC) was performed on tissue microarrays from a large population of 3992 breast cancer patients divided into training and validation cohorts. Consensus staining scores were used to evaluate the expression levels of autophagy proteins LC3B, ATG4B, and GABARAP and determine the associations with clinicopathological variables and molecular biomarkers. Survival analyses were performed using the Kaplan-Meier function and Cox proportional hazards regression models. We found subtype-specific expression differences for ATG4B, with its expression lowest in basal-like breast cancer and highest in Luminal A, but there were no significant associations with patient prognosis. LC3B and GABARAP levels were highest in basal-like breast cancers, and high levels were associated with worse outcomes across all subtypes (DSS; GABARAP: HR 1.43, LC3B puncta: HR 1.43). High ATG4B levels were associated with ER, PR, and BCL2 positivity, while high LC3B and GABARAP levels were ass...Continue Reading

References

Jun 15, 2006·Breast Cancer Research and Treatment·Daniel F HayesMarc E Lippman
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maggie C U CheangAllen M Gown
Feb 13, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·David VoducTorsten Nielsen
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maggie C U CheangTorsten O Nielsen
Apr 10, 2008·International Journal of Cancer. Journal International Du Cancer·François BertucciDaniel Birnbaum
Sep 5, 2008·Molecular Biology of the Cell·Naonobu FujitaTamotsu Yoshimori
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen ChiaKaren Gelmon
May 14, 2009·Journal of the National Cancer Institute·Maggie C U CheangTorsten O Nielsen
Dec 26, 2009·Current Opinion in Cell Biology·Zhifen Yang, Daniel J Klionsky
Jun 29, 2010·Autophagy·Hilla WeidbergZvulun Elazar
Oct 21, 2010·Physiological Reviews·Brinda RavikumarDavid C Rubinsztein
Feb 10, 2011·The Oncologist·Charles M Perou
May 17, 2011·Breast Cancer Research and Treatment·Rinat YerushalmiHagen Kennecke
Aug 2, 2011·Annual Review of Cell and Developmental Biology·Noboru MizushimaYoshinori Ohsumi
Aug 27, 2011·Genome Biology·Tomer ShpilkaZvulun Elazar
Nov 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rossitza LazovaJohn M Pawelek
Jun 2, 2012·Autophagy·Zhong-Qiu YuZhiping Xie
Oct 25, 2012·Biochemia Medica·Mary L McHugh
Dec 18, 2012·Autophagy·Wim MartinetGuido R Y De Meyer
Oct 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sheng ChenZhi-Ming Shao
Nov 5, 2013·Biochemical and Biophysical Research Communications·Elisa TranUrban Emmenegger
Dec 25, 2013·Cell Research·Yuchen FengDaniel J Klionsky
Jul 6, 2014·Autophagy·Pei-Feng LiuChih-Wen Shu
Aug 13, 2014·World Journal of Clinical Oncology·Paola Maycotte, Andrew Thorburn
Feb 26, 2015·The EMBO Journal·Lorenzo GalluzziGuido Kroemer
Aug 5, 2015·Cold Spring Harbor Protocols·Suganthi ChittaranjanSharon M Gorski
Sep 18, 2015·The Journal of Biological Chemistry·Zhifen YangJohn C Reed
Aug 25, 2016·Oncotarget·Svetlana BortnikSharon M Gorski
Sep 8, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marco B E SchaafKasper M A Rouschop

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.